|
| 37540500 | Beyond genetics: Deciphering the impact of missense variants in CAD deficiency. | J Inherit Metab Dis | 2023 |
| 36357165 | Homozygous truncating variant in <i>MAN2A2</i> causes a novel congenital disorder of glycosylation with neurological involvement. | J Med Genet | 2023 |
| 36214423 | DDOST-CDG: Clinical and molecular characterization of a third patient with a milder and a predominantly movement disorder phenotype. | J Inherit Metab Dis | 2023 |
| 36423686 | GLUT1 is a highly efficient L-fucose transporter. | Journal of Biological Chemistry | 2023 |
| 37711075 | Biallelic missense variants in COG3 cause a congenital disorder of glycosylation with impairment of retrograde vesicular trafficking. | J Inherit Metab Dis | 2023 |
| 36719165 | Elevated oxysterol and N-palmitoyl-O-phosphocholineserine levels in congenital disorders of glycosylation. | J Inherit Metab Dis | 2023 |
| 36651831 | Fractionated plasma N-glycan profiling of novel cohort of ATP6AP1-CDG subjects identifies phenotypic association. | J Inherit Metab Dis | 2023 |
| 36636598 | The Swedish COG6-CDG experience and a comprehensive literature review. | | 2023 |
| 35242569 | Uridine monophosphate (UMP)-responsive developmental and epileptic encephalopathy: A case report of two siblings and a review of literature. | Molecular Genetics and Metabolism Reports | 2022 |
| 35932216 | A recurrent homozygous missense DPM3 variant leads to muscle and brain disease. | Clin Genet | 2022 |
| 35790351 | Clinical, biochemical and genetic characteristics of MOGS-CDG: a rare congenital disorder of glycosylation. | J Med Genet | 2022 |
| 36053214 | Origin of cytoplasmic GDP-fucose determines its contribution to glycosylation reactions. | Journal of Cell Biology | 2022 |
| 36393834 | COG4 mutation in Saul-Wilson syndrome selectively affects secretion of proteins involved in chondrogenesis in chondrocyte-like cells. | Front Cell Dev Biol | 2022 |
| 35716054 | ALG8-CDG: Molecular and phenotypic expansion suggests clinical management guidelines. | J Inherit Metab Dis | 2022 |
| 34788024 | Chemical Therapies for Congenital Disorders of Glycosylation. | ACS Chemical Biology | 2022 |
| 35262690 | CAMLG-CDG: a novel congenital disorder of glycosylation linked to defective membrane trafficking. | Hum Mol Genet | 2022 |
| 34595172 | A Dominant Heterozygous Mutation in Causes Saul-Wilson Syndrome, a Primordial Dwarfism, and Disrupts Zebrafish Development via Wnt Signaling. | Frontiers in Cell and Developmental Biology | 2021 |
| 33964207 | A mutation in SLC37A4 causes a dominantly inherited congenital disorder of glycosylation characterized by liver dysfunction. | Am J Hum Genet | 2021 |
| 33583022 | Expanding the phenotype, genotype and biochemical knowledge of ALG3-CDG. | J Inherit Metab Dis | 2021 |
| 33734437 | ALG13 X-linked intellectual disability: New variants, glycosylation analysis, and expanded phenotypes. | J Inherit Metab Dis | 2021 |
| 34245688 | SLC37A4-CDG: New biochemical insights for an emerging congenital disorder of glycosylation with major coagulopathy. | Clin Chim Acta | 2021 |
| 34653363 | Active site variants in STT3A cause a dominant type I congenital disorder of glycosylation with neuromusculoskeletal findings. | Am J Hum Genet | 2021 |
| 31398011 | Therapeutic Monosaccharides: Looking Back, Moving Forward. | Biochemistry | 2020 |
| 31949312 | Defining the clinical phenotype of Saul-Wilson syndrome. | Genet Med | 2020 |
| 32395830 | Mutations in GET4 disrupt the transmembrane domain recognition complex pathway. | J Inherit Metab Dis | 2020 |
| 32049367 | Expanding the molecular and clinical phenotypes of FUT8-CDG. | Journal of Inherited Metabolic Disease | 2020 |
| 32461667 | Cell-based analysis of CAD variants identifies individuals likely to benefit from uridine therapy. | Genet Med | 2020 |
| 33204592 | MPI-CDG from a hepatic perspective: Report of two Egyptian cases and review of literature. | JIMD Reports | 2020 |
| 30770273 | Arrest of Fetal Brain Development in ALG11-Congenital Disorder of Glycosylation. | Pediatr Neurol | 2019 |
| 31875565 | N-Glycanase 1 Transcriptionally Regulates Aquaporins Independent of Its Enzymatic Activity. | Cell Reports | 2019 |
| 30117111 | DPAGT1 Deficiency with Encephalopathy (DPAGT1-CDG): Clinical and Genetic Description of 11 New Patients. | JIMD Rep | 2019 |
| 30701557 | Factor VIII and vWF deficiency in STT3A-CDG. | Journal of Inherited Metabolic Disease | 2019 |
| 30817854 | SLC35A2-CDG: Functional characterization, expanded molecular, clinical, and biochemical phenotypes of 30 unreported Individuals. | Hum Mutat | 2019 |
| 30746764 | Clinical, neuroradiological, and biochemical features of SLC35A2-CDG patients. | J Inherit Metab Dis | 2019 |
| 30676690 | ALG11-CDG syndrome: Expanding the phenotype. | American Journal of Medical Genetics, Part A | 2019 |
| 30945312 | Mutations in the translocon-associated protein complex subunit SSR3 cause a novel congenital disorder of glycosylation. | J Inherit Metab Dis | 2019 |
| 29321044 | Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation. | Orphanet Journal of Rare Diseases | 2018 |
| 30503518 | Pathogenic Variants in Fucokinase Cause a Congenital Disorder of Glycosylation. | American Journal of Human Genetics | 2018 |
| 30290151 | A Recurrent De Novo Heterozygous COG4 Substitution Leads to Saul-Wilson Syndrome, Disrupted Vesicular Trafficking, and Altered Proteoglycan Glycosylation. | Am J Hum Genet | 2018 |
| 29304374 | Biallelic Mutations in FUT8 Cause a Congenital Disorder of Glycosylation with Defective Fucosylation. | Am J Hum Genet | 2018 |
| 29606283 | Perspectives on Glycosylation and Its Congenital Disorders. | Trends in Genetics | 2018 |
| 28216230 | Activation of a cryptic splice site in the mitochondrial elongation factor GFM1 causes combined OXPHOS deficiency. | Mitochondrion | 2017 |
| 28856833 | Encephalopathy caused by novel mutations in the CMP-sialic acid transporter, SLC35A1. | Am J Med Genet A | 2017 |
| 28218252 | Dissecting the molecular organization of the translocon-associated protein complex. | Nat Commun | 2017 |
| 26335155 | Serum transferrin carrying the xeno-tetrasaccharide NeuAc-Gal-GlcNAc2 is a biomarker of ALG1-CDG. | J Inherit Metab Dis | 2016 |
| 26931382 | ALG1-CDG: Clinical and Molecular Characterization of 39 Unreported Patients. | Hum Mutat | 2016 |
| 26805780 | Mitotic Intragenic Recombination: A Mechanism of Survival for Several Congenital Disorders of Glycosylation. | Am J Hum Genet | 2016 |
| 27325525 | Congenital nephrotic syndrome in an infant with ALG1-congenital disorder of glycosylation. | Pediatrics International | 2016 |
| 27480077 | SRD5A3-CDG: Expanding the phenotype of a congenital disorder of glycosylation with emphasis on adult onset features. | Am J Med Genet A | 2016 |
| 26430078 | A Novel N-Tetrasaccharide in Patients with Congenital Disorders of Glycosylation, Including Asparagine-Linked Glycosylation Protein 1, Phosphomannomutase 2, and Mannose Phosphate Isomerase Deficiencies. | Clin Chem | 2016 |